DNA X, Inc. SONM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -20.66M | -33.38M | -31.14M |
| Total Depreciation and Amortization | -- | -- | 4.30M | 232.00K | 198.00K |
| Total Amortization of Deferred Charges | -- | -- | 2.07M | 7.84M | 7.84M |
| Total Other Non-Cash Items | -- | -- | -4.15M | -1.58M | -349.00K |
| Change in Net Operating Assets | -- | -- | -5.09M | 868.00K | 4.04M |
| Cash from Operations | -- | -- | -23.53M | -26.03M | -19.41M |
| Capital Expenditure | -- | -- | -- | -8.00K | -145.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -8.00K | -145.00K |
| Total Debt Issued | -- | -- | 6.37M | 5.70M | 3.38M |
| Total Debt Repaid | -- | -- | -555.00K | -591.00K | -591.00K |
| Issuance of Common Stock | -- | -- | 13.67M | 14.01M | 9.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 19.49M | 19.12M | 11.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -4.04M | -6.92M | -7.59M |